Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo

Several studies indicate that erythropoietin (EPO) has remarkable neuroprotective effects in various central nervous system disorders, while little is known about the effects of EPO in diabetes-associated cognitive dysfunction. Therefore, the present study aimed to investigate whether EPO ameliorate...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meng, Yan, Wenhui, Liu, Yuan, Hu, Hao, Sun, Qiang, Chen, Xinlin, Zang, Weijin, Chen, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459814/
https://www.ncbi.nlm.nih.gov/pubmed/28584284
http://dx.doi.org/10.1038/s41598-017-03137-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459814/
https://www.ncbi.nlm.nih.gov/pubmed/28584284
http://dx.doi.org/10.1038/s41598-017-03137-6

Ejemplares similares